Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Clinical trial NCT04535271 · RECRUITING
Trial details
- NCT number
- NCT04535271
- Sponsor
- Sarcoma Oncology Research Center, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2028-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.